CANCER INCIDENCE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND A PRIOR NON-DIGESTIVE MALIGNANCY ACCORDING TO THE IMMUNOMODULATORY THERAPY: A MULTICENTER COHORT STUDY

Florian Poullenot  ¹     Aurelien Amiot  ²     Maria Nachury  ³     Stéphanie Viennot  ⁴     Romain Altwegg  ⁵     Yoram Bouhnik  ⁶     Vered Abitbol  ⁷     Stephane NANCEY  ⁸     Lucine Vuitton  ⁹     Laurent Peyrin-Biroulet  ¹⁰     Guillaume Cadiot  ¹¹     Mathurin Fumery  ¹²     Laurence Picon  ¹³     Mathias Vidon  ¹⁴     Catherine Reenaers  ¹⁵     Mélanie Serrero  ¹⁶     Guillaume Savoye  ¹⁷     Laurent Beaugerie  ¹⁸     Pauline Riviere     David Laharie    
¹ Bordeaux University Hospital, Pessac, France
² Henri Mondor Hospital, Creteil, France
³ CHRU Lille, Lille, France
⁴ CHRU de Caen, Caen Cedex, France
⁵ Hopital Saint Eloi, Montpellier cedex 5, France
⁶ CHU Beaujon, Clichy, France
⁷ Hopital Cochin, Paris Cedex 14, France
⁸ Hôpital Lyon Sud, Lyon, France
⁹ Besançon University Hospital, Besancon, France
¹⁰ Nancy University Hospital Inserm U954, Vandoeuvre les Nancy, France
¹¹ Hôpital Robert Debré, Reims Cedex, France
¹² Amiens University Hospital, Amiens, France
¹³ CHU, Tours, France
¹⁴ Hôpital Intercommunal Créteil, Creteil Cedex, France
¹⁵ CHU de Liège Sart Tilman, Liege, Belgium
¹⁶ Hopital Nord, Marseille, France
¹⁷ Hopiaux de Rouen, Rouen, France
¹⁸ Saint-Antoine Hospital, Paris, France

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)